Found 15 matching trials
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy N/A Hormone receptor-positive breast cancer accounts for about 70% of all breas...
Show More Location
Cancer Hospital Affiliated to Harbin Medical University
Learn More & Join Trial
Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET PHASE2 The object of this study is to evaluate the efficacy of extended letrozole ...
Show More Location
Obstetrics &Gynecology Department , Faculty of medicine ,Cairo university
Learn More & Join Trial
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer PHASE3 RATIONALE: Estrogen can cause the growth of breast cancer cells. Letrozole ...
Show More Location
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
Learn More & Join Trial
Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen PHASE1 Primary Objective:
The purpose of this study was to determine the long ter...
Show More Location
Investigational Site Number 840010
Learn More & Join Trial
Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study PHASE3 TOL2506A (OVELIA) is a Phase 3, single arm, open-label study evaluating the...
Show More Status
Enrolling By Invitation
Location
Marin Cancer Care, Inc.
Learn More & Join Trial
Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer PHASE3 Based on the risk of late recurrence in breast cancer patients with luminal...
Show More Learn More & Join Trial
Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients N/A Title of study: An observational, multicenter study on the safety and effic...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy PHASE2 Breast cancer is the most common malignancy in the U.S. Targeted therapies ...
Show More Status
Active Not Recruiting
Location
University of Alabama - Birmingham
Learn More & Join Trial
Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene PHASE4 The purpose of this study is to assess Efficacy and Safety of Extended Adju...
Show More Location
Department of Surgery, Asan medical center
Learn More & Join Trial
Extended Endocrine Therapy for Premenopausal Women With Breast Cancer PHASE2 The purpose of this study is to determine the safety and tolerability of th...
Show More Location
University of Colorado
Learn More & Join Trial